InvestorsHub Logo
Followers 40
Posts 866
Boards Moderated 0
Alias Born 01/13/2011

Re: C-20 post# 175551

Friday, 07/23/2021 8:02:28 PM

Friday, July 23, 2021 8:02:28 PM

Post# of 233271
C-20, because we don't have anything from the 13D group re: their plans and because they haven't addressed the multitude of concerns, I can only draw, at least for me, one logical conclusion. My conclusion is that the concerns many have rightly expressed must be at the very least, partially, if not completely true. What other possible reason could there be for their silence in not addressing the concerns presented to them. I agree that they know what the raised concerns are unless they are completely oblivious, in which case it speaks to yet another reason we don't want them at the helm.

NP may not be the best choice but I have yet to see a better one who is qualified to step into his position at this point and not set us back, considerably. Regardless of what some may think of NP, what is undeniable, is that leronlimab is no longer sitting, forgotten, on a shelf. Many are now looking very closely and following the trials and hearing about the safe and positive results shown thus far. We are slowly gaining ground. The 'slow' part of this is painful to watch when you consider how many people have needlessly died because of all the road blocks that have been thrown up in an attempt to slow us down or even stop us. The list of documented offenders is too long to begin to list. In spite of all the attempts to thwart leronlimab, NP has continued to trudge forward, gaining ground. Sometimes it's ten steps forward and 3 steps back but the net effect is positive.

All in my opinion of course.

All IMHO

"Falsus in unum, falsus in omnibus" / “Lie about one thing, lie about it all”

"The greatest obstacle to discovering the shape of the earth, the continents, and the oceans was not ignorance, but the illusion of knowledge" -Daniel J. Boorstin

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News